Oxford Cannabinoid Technologies Holdings (FRA:0CB) Cash-to-Debt

: No Debt ⁽¹⁾ (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Oxford Cannabinoid Technologies Holdings's cash to debt ratio for the quarter that ended in Oct. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Oxford Cannabinoid Technologies Holdings could pay off its debt using the cash in hand for the quarter that ended in Oct. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Cash-to-Debt or its related term are showing as below:

FRA:0CB' s Cash-to-Debt Range Over the Past 10 Years
Min: 2.89 Med: 5109.23 Max: No Debt
Current: No Debt

During the past 5 years, Oxford Cannabinoid Technologies Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 2.89. And the median was 5109.23.

FRA:0CB's Cash-to-Debt is ranked better than
99.74% of 1540 companies
in the Biotechnology industry
Industry Median: 6.495 vs FRA:0CB: No Debt

Oxford Cannabinoid Technologies Holdings Cash-to-Debt Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

Cash-to-Debt

No Debt

2.88

84.38

No Debt

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Cash-to-Debt					84.38	217.94	No Debt	No Debt	No Debt

Competitive Comparison

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Cannabinoid Technologies Holdings Cash-to-Debt Distribution

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Cash-to-Debt falls into.

Oxford Cannabinoid Technologies Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Oxford Cannabinoid Technologies Holdings's Cash to Debt Ratio for the fiscal year that ended in Apr. 2023 is calculated as:

Oxford Cannabinoid Technologies Holdings had no debt ⁽¹⁾.

Oxford Cannabinoid Technologies Holdings's Cash to Debt Ratio for the quarter that ended in Oct. 2023 is calculated as:

Oxford Cannabinoid Technologies Holdings had no debt ⁽¹⁾.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Oxford Cannabinoid Technologies Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

OCTP:UK

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines